Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NK | AMGN | GILD | VRTX | BIIB |
| Company | Nantkwest Inc CS | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 30.34 | 337.03 | 84.39 | 477.70 | 200.57 |
| High | 33.15 | 338.70 | 84.65 | 481.70 | 204.18 |
| Low | 29.74 | 334.61 | 83.57 | 476.27 | 200.11 |
| Last | 32.49 | 336.99 | 83.94 | 481.47 | 201.55 |
| Change | +4.21 | +4.07 | +0.05 | +7.31 | +3.96 |
| % Change | +14.89% | +1.22% | +0.06% | +1.54% | +2.00% |
| Volume | 1,109,000 | 393,384 | 1,983,818 | 188,184 | 318,832 |
| 20-Day Average Volume | 1,620,320 | 1,697,244 | 6,346,599 | 948,341 | 787,499 |
| Previous Close | 28.28 | 332.92 | 83.89 | 474.16 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.51 | 329.62 | 80.08 | 480.00 | 201.67 |
| 20-Day Raw Stochastic | 41.94% | 88.35% | 91.41% | 50.44% | 72.33% |
| 20-Day Relative Strength | 58.89% | 58.20% | 72.20% | 50.76% | 46.92% |
| Weighted Alpha | +342.67 | +27.47 | +18.57 | +34.61 | -20.93 |
| Today's Opinion | 100% Buy | 96% Buy | 88% Buy | 56% Buy | 88% Sell |
| Previous Opinion | 80% Buy | 88% Buy | 88% Buy | 40% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.56% since 03/02/21 | +2.00% since 09/12/24 | +1.09% since 09/12/24 | +0.42% since 09/12/24 | +2.45% since 09/12/24 |
| Low | 23.15 on 03/05/21 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 192.25 on 09/13/24 |
| High | 33.15 on 03/09/21 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 490.15 on 09/16/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | +15.79% since 02/09/21 | +2.65% since 08/19/24 | +12.92% since 08/19/24 | -1.52% since 08/19/24 | -1.61% since 08/19/24 |
| Low | 23.15 on 03/05/21 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 45.42 on 02/22/21 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +216.36% since 12/09/20 | +10.03% since 06/18/24 | +33.13% since 06/18/24 | +2.86% since 06/18/24 | -9.35% since 06/18/24 |
| Low | 10.00 on 12/10/20 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 45.42 on 02/22/21 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +393.77% since 09/09/20 | +23.90% since 03/19/24 | +14.52% since 03/19/24 | +15.76% since 03/19/24 | -7.27% since 03/19/24 |
| Low | 6.51 on 09/11/20 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 45.42 on 02/22/21 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,552,620 | 178,589,936 | 104,514,608 | 122,358,416 | 28,768,510 |
| Shares Outstanding, K | 109,345 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 110,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -92,380,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 20,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -32,140,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 2.38 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 03/24/21 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 0.00 | 12.19 |